European Economic
and Social Committee
EU Medical Countermeasures and Stockpiling Strategies
The EU Youth Test at the EESC was applied to this opinion. The ESDN Youth was chosen by a group of interested youth organisations to represent all of them during the opinion-making process.
Key points
The EESC:
- Welcomes the Commission’s efforts to strengthen the EU’s preparedness and resilience through the medical countermeasures and stockpiling strategies and recommends their transparent management and mobilisation, with continuous coordination among Member States, industry and civil society.
- Calls for adequate Multiannual Financial Framework (MFF) resources to support medical countermeasures and strategic stockpiling, encouraging public-private partnerships while avoiding duplication across Member States.
- Urges stable economic, legal and workforce conditions to attract pharmaceutical production in Europe, including a dedicated EU pharmaceutical fund to support facilities, R&D, regulatory costs and investment in active pharmaceutical ingredients and medicines production.
- Supports creating a European health innovation entity (modelled on CERN) to boost research, entrepreneurship and collaboration with HERA and other EU agencies.
- Calls for a concrete operational plan for EU stockpiling with clear funding, transparent EU/national responsibilities, strong workforce training, monitoring and fair incentives for industry, including SMEs.
- Emphasises the need for a transparent economic framework, coordinated logistics, flexible transport rules and fair cost-sharing for rapid deployment of critical goods.
- Stresses involving social partners, civil society and specialised contractors to ensure transparency and technical expertise, prioritising EU-owned safety stocks and support for storage, cold chain and dual-use infrastructure.
- Highlights investment in workforce skills through lifelong learning, harmonised curricula, regular simulations and recognition of public health as a profession, ensuring resilient reserve management and crisis response.
- Advocates sustainable, demand-driven stockpiling supported by real-time digital tracking, product-based thresholds and affordability to ensure fair, transparent and accessible preparedness.
Downloads
-
Record of Proceedings CCMI/251
-
Fact sheet CCMI/251
-
Follow-up from the Commission CCMI/251
Recommended for you
Transitional provisions for certain medical devices and in vitro diagnostic medical devices
Opinion
In vitro diagnostic medical devices
Opinion
BackgroundThe Commission proposal amends Regulation (EU) 2017/746 as regards transitional provisions for certain in vitro diagnostic medical devices and deferred application of requirements for in…
The contribution of the robotics metaverse in the medical sector
Opinion
The EESC:recommends developing a comprehensive regulatory framework for robotics and the metaverse in healthcare;stresses the importance of promoting ethical standards and patient consent protocols…
Eudamed and in-vitro diagnostic medical devices
Opinion
Key pointsThe EESC :calls for the transitional periods for certain high-risk in vitro diagnostic medical devices (IVDs) to be extended and calls for a pragmatic, consistent framework to provide…
Proposal for a Regulation - Targeted revision of the EU rules for medical devices and in vitro diagnostics
Opinion
ENEN INT/1116 – Medical devices and in vitro diagnostics / Simplification Key points The EESC: welcomes the Commission’s proposal to simplify and streamline the Medical Devices Regulation (MDR)…